NantHealth, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 22, 2023 at 04:32 pm EST
Share
NantHealth, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 12.47 million compared to USD 16.63 million a year ago. Net loss was USD 14.99 million compared to USD 13.66 million a year ago. Basic loss per share from continuing operations was USD 1 compared to USD 1.77 a year ago.
For the nine months, revenue was USD 46.78 million compared to USD 49.5 million a year ago. Net loss was USD 44.71 million compared to USD 42.12 million a year ago. Basic loss per share from continuing operations was USD 4.4 compared to USD 5.47 a year ago. Diluted loss per share from continuing operations was USD 4.4 compared to USD 5.47 a year ago.
NantHealth, Inc. provides enterprise solutions that help businesses transform complex data into actionable insights. The Company is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it secure and scalable. The Companyâs products include Eviti Connect and Eviti Advisor, NaviNet, NaviNet Open, NaviNet AllPayer, OpenNMS, and Quadris. Its product portfolio comprises the technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet) and data solutions that include multi-data analysis, reporting, and professional service offerings (Quadris). In addition, The OpenNMS Group, Inc. (OpenNMS), a Companyâs subsidiary, helps businesses monitor and manage network health and performance.
NANTHEALTH, INC. 
